Olivier Jean Bohuon
Net worth: 64 282 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stéphane Thiroloix | M | - |
Algotherapeutix SAS
 Algotherapeutix SAS Medical SpecialtiesHealth Technology AlgoTherapeutix SAS is a clinical-stage biotechnology company based in Suresnes, France. The French company is focused on developing targeted, first-in-class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is a proprietary topical formulation of amitriptyline that targets the signaling pathways involved in the regulation of pain by inhibiting specific nociceptive sodium channel receptors. The company is currently recruiting patients for a phase II clinical trial of 240 patients for chemotherapy-induced neuropathic pain and a phase II proof of concept trial for erythromelalgia. AlgoTherapeutix has secured FDA fast track development status and orphan drug designation in both the US and EU. AlgoTherapeutix has raised EUR 35 million to date and has a consortium of investors, including Relyens Innovation Santé/Turenne Capital, UI Investissement, and angel investors. The company was founded in 2018 by Olivier Jean Bohuon and Stéphane Thiroloix, with Stéphane Thiroloix serving as the CEO since 2018. | 6 years |
| Catheryn O'Rourke | F | 52 | 11 years | |
| Hubert Allen | M | 58 | 18 years | |
| Shannon Eisenhardt | M | - | 1 years | |
| David Darroch | M | 61 | 2 years | |
| Helen Barraclough | F | 45 | 11 years | |
| Masami Iijima | M | 73 | 3 years | |
| Cyrille Yann Nicolas Petit | M | 54 | 12 years | |
| Edmund Harrigan | M | 71 |
Algotherapeutix SAS
Algotherapeutix SAS Medical SpecialtiesHealth Technology AlgoTherapeutix SAS is a clinical-stage biotechnology company based in Suresnes, France. The French company is focused on developing targeted, first-in-class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is a proprietary topical formulation of amitriptyline that targets the signaling pathways involved in the regulation of pain by inhibiting specific nociceptive sodium channel receptors. The company is currently recruiting patients for a phase II clinical trial of 240 patients for chemotherapy-induced neuropathic pain and a phase II proof of concept trial for erythromelalgia. AlgoTherapeutix has secured FDA fast track development status and orphan drug designation in both the US and EU. AlgoTherapeutix has raised EUR 35 million to date and has a consortium of investors, including Relyens Innovation Santé/Turenne Capital, UI Investissement, and angel investors. The company was founded in 2018 by Olivier Jean Bohuon and Stéphane Thiroloix, with Stéphane Thiroloix serving as the CEO since 2018. | 3 years |
| Habib Ramdani | M | 48 | 8 years | |
| Miki Tsusaka | F | 61 | 1 years | |
| Kimberly Reed | F | 53 | 2 years | |
| Susan O’Reilly | F | - | 5 years | |
| Bradley Cannon | M | 56 | 12 years | |
| Marc E. Owen | M | 65 | 7 years | |
| Karin Hoeing | F | - | 4 years | |
| Dame Dowling | M | 71 | 6 years | |
| Robert Alpern | M | 73 | 16 years | |
| Pam Cheng | F | 53 | 4 years | |
| Angela Risley | F | 66 | 7 years | |
| Marybeth Hays | F | 55 | - | |
| Charlotte Schofield | F | - | 2 years | |
| John M. Capek | M | 62 | 18 years | |
| Filippo Catalano | M | - | 3 years | |
| Jesper Brandgaard | M | 60 |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | 3 years |
| Rakesh Narayana | M | 33 | 2 years | |
| Sylvie Gueguen | F | 59 | 6 years | |
| Danielle Leavitt | F | - |
Essex Woodlands Management, Inc.
 Essex Woodlands Management, Inc. Investment ManagersFinance Essex Woodlands Management, Inc. (EW Healthcare Partners) is a private equity firm founded in 1985 by Jim L. Currie and Martin P. Sutter. The firm is headquartered in Houston, Texas. | 2 years |
| Solène Madelpuech | F | 30 | 7 years | |
| John Ryan | M | - | 5 years | |
| James Dinniss | M | - | 5 years | |
| Anthony Grannell | M | - | 5 years | |
| Paul Keogh | M | - | 5 years | |
| Anthony Denis Ahern | M | - | 5 years | |
| Tamara Ingram | F | 63 | 1 years | |
| Charles Reynolds | M | - | 13 years | |
| Rama Donepudi | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Richard Gonzalez | M | 70 | 33 years | |
| Jeffrey Leiden | M | 68 | 6 years | |
| David J. Illingworth | M | 70 | 9 years | |
| Nicandro Durante | M | 67 | 10 years | |
| Susan Kilsby | F | 65 | 8 years | |
| Scott Applebaum | M | 57 | 2 years | |
| Jeffrey Poulton | M | 56 | 14 years | |
| Gitte Pugholm Aabo | F | 57 |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | 27 years |
| Roland Diggelmann | M | 57 | 4 years | |
| Masato Iwasaki | M | 65 | 38 years | |
| Christian Karst | M | 66 | 36 years | |
| Kevin R. Tebbit | M | 76 | 12 years | |
| Catherine Mazzacco | F | 59 |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | 2 years |
| S. Mathew | F | 68 | 7 years | |
| Namal Nawana | M | 53 | 1 years | |
| Souheil Salah | M | - | 16 years | |
| Naseem Amin | M | 62 | 5 years | |
| Jukka Pekka Pertola | M | 64 |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | 8 years |
| David R. Ginsburg | M | 71 | 8 years | |
| James Farrell | M | 81 | - | |
| David Altarac | M | 63 | - | |
| Jeff Carr | M | 61 | 4 years | |
| Rosalind Rivaz | M | 68 | 3 years | |
| Dominic Blakemore | M | 54 | 4 years | |
| Robin Freestone | M | 65 | 7 years | |
| Adam Sharkawy | M | 58 | 9 years | |
| Graham Baker | M | 56 | 3 years | |
| Ian Karp | M | - | 5 years | |
| Aditya Sehgal | M | - | 27 years | |
| Gisele Dion | F | 57 | 5 years | |
| Ludovic Robin | M | - | 8 years | |
| Christoph Brackmann | M | - | - | |
| Sun Kim | M | 52 | 2 years | |
| Joseph Sullivan | M | - | 8 years | |
| Sujata Dayal | F | 61 | 5 years | |
| Michael Frazzette | M | 61 | 11 years | |
| Vinita Kundanlal Bali | F | 67 | 6 years | |
| Richard de Schutter | M | 83 | 13 years | |
| Julie Brown | F | 62 | 4 years | |
| Phebe Novakovic | F | 66 | 11 years | |
| William Burns | M | 76 | 8 years | |
| Laura Schumacher | F | 60 | 5 years | |
| Ian Clark | M | 62 | 2 years | |
| Laxman Narasimhan | M | 56 | 3 years | |
| Glenn Tilton | M | 75 | 16 years | |
| Samuel Scott | M | 79 | 13 years | |
| Edward Liddy | M | 78 | 11 years | |
| William Osborn | M | 76 | 15 years | |
| Christopher Sinclair | M | 72 | 9 years | |
| Steven Gillis | M | 71 | 7 years | |
| Grita Loebsack | F | 54 | 5 years | |
| John Gordon Buchanan | M | 79 | 9 years | |
| Rolf Stomberg | M | 84 | 14 years | |
| Erik Engstrom | M | 60 | 8 years | |
| Terrence Kearney | M | 69 | 25 years | |
| Virginia Hilda Brunette Maxwell Bottomley | F | 76 | 9 years | |
| Ajay Gopikisan Piramal | M | 68 | 2 years | |
| Bruno Francois Jules Angelici | M | 77 | 10 years | |
| Anne Minto | F | 70 | 8 years | |
| Anne Quinn | F | 72 | 9 years | |
| Geneviéve B. Berger | M | 69 | 2 years | |
| Thomas Johannes W. Dittrich | M | 60 | 1 years | |
| Arjun Purkayastha | M | 45 | 10 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 48 | 48.00% |
| Ireland | 24 | 24.00% |
| United States | 16 | 16.00% |
| France | 8 | 8.00% |
| Japan | 5 | 5.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Olivier Jean Bohuon
- Personal Network
